Radiology, Vol 156, 681-688, Copyright © 1985 by Radiological Society of North America

ARTICLES

Brain tumors: MR imaging with gadolinium-DTPA

R Felix, W Schorner, M Laniado, HP Niendorf, C Claussen, W Fiegler and U Speck

Magnetic resonance (MR) imaging was performed on 40 patients with intracranial tumors, before and after intravenous administration of gadolinium-DTPA (Gd-DTPA). Precontrast studies included a comprehensive protocol of spin-echo sequences. Tumors were visualized on precontrast images either directly or indirectly by anatomic distortion caused by the mass. However, differentiation of the tumor from adjacent tissues was possible in only 17 of 40 cases. Delineation of the tumor was best on precontrast, T2-weighted images. After administration of Gd-DTPA (0.1 mmol/kg), increased signal intensity from the tumor was observed in all patients. The localized increase in signal intensity in the tumor considerably improved the tumor delineation in 36 of 40 patients. Whereas most of the meningiomas, neuromas, and adenomas could be delineated prior to administration of contrast material if appropriate pulse sequences were applied, glioblastomas and intracranial metastases required Gd-DTPA administration for diagnostically sufficient tumor display.

This article has been cited by other articles:

				S. Tezelman, Y. Giles, F. Tunca, K. Gok, A. Poyanli, A. Salmaslioglu, and T. Terzioglu Diagnostic Value of Dynamic Contrast Medium Enhanced Magnetic Resonance Imaging in Preoperative Detection of Thyroid Carcinoma Arch Surg, November 1, 2007; 142(11): 1036 - 1041. [Abstract] [Full Text] [PDF]

				M. A. Jacobs, T. S. Ibrahim, and R. Ouwerkerk AAPM/RSNA Physics Tutorials AAPM/RSNA Physics Tutorials for Residents: MR Imaging: Brief Overview and Emerging Applications RadioGraphics, July 1, 2007; 27(4): 1213 - 1229. [Abstract] [Full Text] [PDF]

				M. Law, S. Yang, H. Wang, J. S. Babb, G. Johnson, S. Cha, E. A. Knopp, and D. Zagzag Glioma Grading: Sensitivity, Specificity, and Predictive Values of Perfusion MR Imaging and Proton MR Spectroscopic Imaging Compared with Conventional MR Imaging AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1989 - 1998. [Abstract] [Full Text] [PDF]

				S. Cha, E. A. Knopp, G. Johnson, A. Litt, J. Glass, M. L. Gruber, S. Lu, and D. Zagzag Dynamic Contrast-enhanced T2*-weighted MR Imaging of Recurrent Malignant Gliomas Treated with Thalidomide and Carboplatin AJNR Am. J. Neuroradiol., May 1, 2000; 21(5): 881 - 890. [Abstract] [Full Text]

				E. A. Knopp, S. Cha, G. Johnson, A. Mazumdar, J. G. Golfinos, D. Zagzag, D. C. Miller, P. J. Kelly, and I. I. Kricheff Glial Neoplasms: Dynamic Contrast-enhanced T2*-weighted MR Imaging Radiology, June 1, 1999; 211(3): 791 - 798. [Abstract] [Full Text]

				J. Breslau, J. G. Jarvik, D. R. Haynor, W. T. Longstreth Jr, D. L. Kent, and K. R. Maravilla MR Contrast Media in Neuroimaging: A Critical Review of the Literature AJNR Am. J. Neuroradiol., April 1, 1999; 20(4): 670 - 675. [Abstract] [Full Text]